JHP To Manufacture Life-Saving Drug

JHP Pharmaceuticals has entered into an agreement with an undisclosed pharmaceutical company for the product transfer and registration batch production of a life-saving drug.

Stuart Hinchen, chief executive officer and president of JHP, said, “Our cGMP compliance record and experienced staff allow us to effectively serve this important customer. JHP’s history of manufacturing DEA-regulated products is vital in producing this terminally sterilized life-saving drug. We see this partnership as another opportunity to demonstrate our customer-focused approach in the manufacture of quality-driven products that save patient lives.”